Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

✍ Scribed by M. Onofrj; A. Thomas; F. Vingerhoets; W. Martin; S. Giménez-Roldán; J.-P. Azulay; G. Bernhard; W. Schmidt; S. Markabi

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 292 KB
• Volume: 111
• Category: Article
• ISSN: 1435-1463
• DOI: 10.1007/s00702-004-0149-4